Lucid Diagnostics Inc. — Director's Dealing 2024

Feb 23, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2024-02-22

Reporting Person: Lapidus Stanley (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-22	Employee stock option (right to buy)	$1.23	A	150000	Acquired	2034-02-22	Common stock (150000)	Direct

Footnotes

F1: One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025.